Generalized Pustular Psoriasis
📧 Sign up to get email alerts when something new happens for Generalized Pustular Psoriasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-10-21FDA Approved: SPEVIGO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SPEVIGO (spesolimab-sbzo) from Boehringer Ingelheim Pharmaceuticals, finalizing changes to i…
-
FDA approval · 2022-09-01FDA Approved: SPEVIGO — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved SPEVIGO (spesolimab-sbzo) from Boehringer Ingelheim in an original application for generalized pustular psoriasis.